TOP TIERMARKET NEWSWIRE
News & sentiment

NEWAMSTERDAM PHARMA (NAMS) — News & AI sentiment

NEWAMSTERDAM PHARMA (NAMS) news roundup. 2 stories in the last 24 hours, 5 in the past week, 11 over 30 days. Average 24-hour sentiment is 56/100 — neutral (50 is neutral). Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 3 sales totalling $6.7M — net selling of $6.7M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
2
avg sentiment 56/100
7d stories
5
avg sentiment 59.2/100
30d stories
11
avg sentiment 54.5/100
Insider net (90d)
$6.7M
0 buys · 3 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on NAMS

20h ago
20h ago
4d ago
6d ago
6d ago
Jul 22
Jul 22
Jefferies reiterates NewAmsterdam Pharma stock rating ahead of data
Investing.com Analyst Ratings56 · neutralanalyst
Jul 20
Why is NewAmsterdam Pharma stock sliding today?
Investing.com Markets42 · neutralgeneral
Jul 20
Jul 2
Jul 1
Jun 10
Jun 8
Jun 3
May 28
Open NAMS in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →